Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
pyridoclax induced apoptosis in combination with Bcl-xL-targeting siRNA or with ABT-737 in ovarian
but dose-dependently (10
The drug-treated groups reveal lower expression of p-STAT3 compared to the CAC group
Tectoridin induces estrogenic effect
Smiles: CC(C)=CCC/C(/C)=C/CC/C(/C)=C/CC/C=C(\C)/CC/C=C(\C)/CCC=C(C)C
MI-192 nt 1 pyridoclax induced apoptosis in combinationMI 192 is a histone deacetylases (HDACs) inhibitor that preferentially inhibits HDAC2 and HDAC3 with IC50 values of 30 nM and 16 nM, respectively . Histone acetylation is the most commonly employed mechanism utilized by transcription factors to activate gene expression. Conversely, histone deacetylation is the most common mechanism used to inactivate genes. Histone deacetylase inhibitors (HDACIs) are in advanced clinical development as cancer
US$ 20.00
US$ 20.00
US$ 1312.50
US$ 124.00
US$ 12.00
US$ 60.00
US$ 10.00
US$ 110.00
US$ 20.00
US$ 18.00
US$ 11.40
US$ 20.00
US$ 21.60
US$ 150.00